advertisement
9.2.1 Ocular hypertension (5)
Showing records 1 to 5
Display all abstracts in classification 9.2.1 Ocular hypertension
Search within classification 9.2.1 Ocular hypertension50482 Risk Calculation Variability Over Time in Ocular Hypertensive Subjects
Song C; De Moraes CG; Forchheimer I; Prata TS; Ritch R; Liebmann JM
Journal of Glaucoma 2014; 23: 1-4
50403 An Evaluation of Therapeutic Noninferiority of 0.005% Latanoprost Ophthalmic Solution and Xalatan in Patients With Glaucoma or Ocular Hypertension
Digiuni M; Manni G; Vetrugno M; Uva M; Milano G; Orzalesi N; Fogagnolo P; Centofanti M; Campos E; Rossetti L
Journal of Glaucoma 2013; 22: 707-712
50465 Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Pfennigsdorf S; Ramez O; von Kistowski G; Mä,der B; Eschstruth P; Frobö,se M; Thelen U; Spraul C; Schnober D; Cooper H; Laube T
Clinical Ophthalmology 2012; 6: 739-746
50477 The Effect of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics in Patients With Ocular Hypertension and Primary Open-angle Glaucoma
Beltran-Agullo L; Alaghband P; Obi A; Husain R; Lim KS
Journal of Glaucoma 2013; 22: 746-749
50515 Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
Burr JM; Botello-Pinzon P; Takwoingi Y; Herná,ndez R; Vazquez-Montes M; Elders A; Asaoka R; Banister K; van der Schoot J; Fraser C; King A; Lemij H; Sanders R; Vernon S; Tuulonen A; Kotecha A; Glasziou P; Garway-Heath D; Crabb D; Vale L; Azuara-Blanco A; Perera R; Ryan M; Deeks J; Cook J.
Health Technol Assess 2012; 16: 1-271
